CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
TetraGraph NMT Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05964166
NCT05964166N/ACompleted
CompareCT.gov

Tetragraph® Monitor: Tolerance of Preoperative Placement

Joseph D. Tobias·interventional·Posted Jul 27, 2023·Updated Nov 18, 2024

In Brief

A clinical study evaluating TetraGraph NMT Monitor for Surgery. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a prospective, non-blinded, single arm study. The primary objective of this study is to evaluate the tolerance to preoperative placement of the adhesive sensor for the Tetragraph® Neuromuscular Transmission Monitor in pediatric-sized patients ≤ 12 years of age.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgery
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 27, 2023
Enrollment StartMay 31, 2023
Primary CompletionAug 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.9 years ago

Interventions

TetraGraph NMT Monitordevice

TetraGraph is a unique, EMG=based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.